Article
AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Image Credit: © Sebastian Kaulitzki – stock.adobe.com Pfizer has announced positive results from the Phase III BREAKWATER clinical trial of Braftovi (encorafenib) in combination with […]
ACT: Where do you think industry currently is with improving diversity in clinical trials? Saarony: It’s not where it needs to be. I say this […]
Image Credit: © photon_photo – stock.adobe.com The FDA has cleared Vir Biotechnology’s investigational new drug (IND) application and granted Fast Track designation for the combination […]